Related Experiment Video
Updated: Jul 10, 2026

09:14
Cardiac Magnetic Resonance Imaging at 7 Tesla
Published on: January 6, 2019
Microtesla extremely low frequency magnetic fields may ameliorate hypertension
Tsutomu Nishimura1, Kaneo Mohri, Harue Tada
1Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Kyoto, Japan.
Georgian Medical News
|November 7, 2007
Summary
Extremely low frequency magnetic fields (ELFMF) show potential for lowering blood pressure. This study found a significant hypotensive effect, especially in hypertensive individuals, after micro-Tesla ELFMF exposure.
Area of Science:
- Biophysics
- Cardiovascular Physiology
- Electromagnetic Medicine
Background:
- Blood pressure regulation is crucial for cardiovascular health.
- Extremely low frequency magnetic fields (ELFMF) are ubiquitous and their biological effects are under investigation.
- Previous research suggests potential non-thermal biological effects of ELFMF.
Purpose of the Study:
- To investigate the effects of a micro-Tesla extremely low frequency magnetic field (microT ELFMF) on human blood pressure.
- To determine if ELFMF exposure has a hypotensive effect, particularly in individuals with hypertension.
Main Methods:
- Thirty volunteers were exposed to a 1-muT, 8/6-Hz alternating current magnetic field generated by Helmholtz coils.
- Blood pressure was measured at baseline, and at 1, 2, and 3 months post-exposure.
- Systolic blood pressure (SBP) changes were analyzed in hypertensive and normotensive subgroups.
Main Results:
- A statistically significant decrease in pre-exposure SBP was observed at 3 months in both hypertensive (p<0.001) and normotensive (p=0.013) subgroups.
- The hypertensive subgroup exhibited a greater reduction in SBP compared to the normotensive subgroup.
- The median number of sessions was 31.5, with a median duration of 10 minutes per session.
Conclusions:
- Micro-Tesla ELFMF exposure may possess a hypotensive effect.
- The hypotensive effect appears more pronounced in individuals with hypertension.
- Further research is warranted to elucidate the mechanisms and clinical applicability of ELFMF for blood pressure management.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
